# Outcome of Pulpotomy With MTA and Biodentin in Permanent Teeth With Caries Exposure

> **NCT06913283** · NA · NOT_YET_RECRUITING · sponsor: **Altamash Institute of Dental Medicine** · enrollment: 136 (estimated)

## Conditions studied

- Pulpitis - Irreversible

## Interventions

- **PROCEDURE:** Pulp Therapy with Mineral trioxide aggregate (MTA)
- **PROCEDURE:** Pulp Therapy with Biodentine

## Key facts

- **NCT ID:** NCT06913283
- **Lead sponsor:** Altamash Institute of Dental Medicine
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2025-05-02
- **Primary completion:** 2025-06
- **Final completion:** 2025-07
- **Target enrollment:** 136 (ESTIMATED)
- **Last updated:** 2025-04-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06913283

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06913283, "Outcome of Pulpotomy With MTA and Biodentin in Permanent Teeth With Caries Exposure". Retrieved via AI Analytics 2026-09-03 from https://api.ai-analytics.org/clinical/NCT06913283. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*